Cargando…

Nurse-administered intravitreal injections of anti-VEGF: study protocol for noninferiority randomized controlled trial of safety, cost and patient satisfaction

BACKGROUND: Intravitreal injections (IVI) of anti-vascular endothelial growth factor (anti-VEGF) now improve or stabilize visual acuity in a number of previously untreatable eye diseases, of which the main are age-related macular degeneration, retinal vein occlusion and diabetic macular edema. Most...

Descripción completa

Detalles Bibliográficos
Autores principales:	Austeng, Dordi, Morken, Tora Sund, Bolme, Stine, Follestad, Turid, Halsteinli, Vidar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045663/ https://www.ncbi.nlm.nih.gov/pubmed/27716253 http://dx.doi.org/10.1186/s12886-016-0348-4

Ejemplares similares

Cost consequences of task-shifting intravitreal injections from physicians to nurses in a tertiary hospital in Norway
por: Bolme, Stine, et al.
Publicado: (2023)

Task shifting of intravitreal injections from physicians to nurses: a qualitative study
por: Bolme, Stine, et al.
Publicado: (2021)

Patient satisfaction following a switch from treat-and-extend to observe-and-plan regimen in age-related macular degeneration
por: Morken, Tora Sund, et al.
Publicado: (2022)

Visuopathy of prematurity: is retinopathy just the tip of the iceberg?
por: Ingvaldsen, Sigrid Hegna, et al.
Publicado: (2021)

Deep learning identify retinal nerve fibre and choroid layers as markers of age‐related macular degeneration in the classification of macular spectral‐domain optical coherence tomography volumes
por: Tvenning, Arnt‐Ole, et al.
Publicado: (2022)

Retinal structure and visual pathway function at school age in children born extremely preterm: a population-based study
por: Ingvaldsen, Sigrid Hegna, et al.
Publicado: (2023)

Retinopathy of prematurity: inflammation, choroidal degeneration, and novel promising therapeutic strategies
por: Rivera, José Carlos, et al.
Publicado: (2017)

Short and long-term clinical effectiveness and cost-effectiveness of a late-phase community-based balance and gait exercise program following hip fracture. The EVA-Hip Randomised Controlled Trial
por: Taraldsen, Kristin, et al.
Publicado: (2019)

Inflammatory Complications of Intravitreal Anti-VEGF Injections
por: Cox, Jacob T., et al.
Publicado: (2021)

Hypotony Maculopathy Related to Anti-VEGF Intravitreal Injection
por: Lima-Fontes, Mário, et al.
Publicado: (2022)

Current Evidence for the Prevention of Endophthalmitis in Anti-VEGF Intravitreal Injections
por: Lau, P. ET., et al.
Publicado: (2018)

Estimation of the need for bilateral intravitreal anti-VEGF injections in clinical practice
por: Giocanti-Auregan, Audrey, et al.
Publicado: (2016)

Guidance for anti-VEGF intravitreal injections during the COVID-19 pandemic
por: Korobelnik, Jean-François, et al.
Publicado: (2020)

The Association of Intravitreal Anti-VEGF Injections With Kidney Function in Diabetic Retinopathy
por: Bunge, Casey C., et al.
Publicado: (2023)

Treatment of large avascular retinal pigment epithelium detachments in age-related macular degeneration with aflibercept, photodynamic therapy, and triamcinolone acetonide
por: Tvenning, Arnt-Ole, et al.
Publicado: (2019)

Practice patterns of ophthalmologists administering intravitreal injections in Europe: a longitudinal survey
por: Huang, Kui, et al.
Publicado: (2016)

Intravitreally Injected Anti-VEGF Antibody Reduces Brown Fat in Neonatal Mice
por: Jo, Dong Hyun, et al.
Publicado: (2015)

Retinal reperfusion in diabetic retinopathy following treatment with anti-VEGF intravitreal injections
por: Levin, Ariana M, et al.
Publicado: (2017)

Concentrations of VEGF and PlGF Decrease in Eyes After Intravitreal Conbercept Injection
por: Zhou, Jun, et al.
Publicado: (2018)

Intravitreal Injection of Anti-VEGF Antibody Induces Glomerular Endothelial Cells Injury
por: Touzani, F., et al.
Publicado: (2019)

Use of Artificial Tears in Patients Undergoing Treatment with Anti-VEGF Intravitreal Injections
por: Pastor-Pascual, Francisco, et al.
Publicado: (2022)

Observation of total VEGF level in hyperglycemic mouse eyes after intravitreal injection of the novel anti-VEGF drug conbercept
por: Du, Liping, et al.
Publicado: (2015)

Patient Satisfaction of Intravitreal Bevacizumab Injection Services at a Referral Center
por: Shayan, Maryam, et al.
Publicado: (2021)

Antiseptic effect of low-concentration povidone-iodine applied with a depot device in the conjunctiva before cataract surgery
por: Wass, Simon, et al.
Publicado: (2018)

Incidence of endophthalmitis after intravitreal injection of an anti-VEGF agent with or without topical antibiotics
por: Morioka, Masakazu, et al.
Publicado: (2020)

Intravitreal vascular endothelial growth factor (VEGF) inhibitor injection in patient during pregnancy
por: Kianersi, Farzan, et al.
Publicado: (2021)

Potential bias of preoperative intravitreal anti-VEGF injection for complications of proliferative diabetic retinopathy
por: Takayama, Kei, et al.
Publicado: (2021)

Hydrophilic Lens Opacification after Intravitreal Anti-VEGF Injections: A Case Series
por: Wahab, Charbel, et al.
Publicado: (2022)

Acute macular neuroretinopathy associated with intravitreal anti-VEGF injection: A case report
por: Radwan, Loubna M., et al.
Publicado: (2022)

Bacterial endophthalmitis following anti-VEGF intravitreal injections: a retrospective case series
por: Bergamo, Vinicius Campos, et al.
Publicado: (2023)

Defining the noninferiority margin and analysing noninferiority: An overview
por: Althunian, Turki A., et al.
Publicado: (2017)

Transient effect of melatonin treatment after neonatal hypoxic-ischemic brain injury in rats
por: Berger, Hester Rijkje, et al.
Publicado: (2019)

Allometric Considerations on Proteins Administered Intravitreally to Children
por: Eissing, Thomas
Publicado: (2018)

Concomitant bilateral intravitreal anti-VEGF injections for the treatment of exudative age-related macular degeneration
por: Davis, R Prince, et al.
Publicado: (2010)

Comparison of Systemic Adverse Events Associated with Intravitreal Anti-VEGF Injection: Ranibizumab versus Bevacizumab
por: Hwang, Duck Jin, et al.
Publicado: (2012)

Incidence of ocular hypertension after intravitreal injection of anti-VEGF agents in the treatment of neovascular AMD
por: Moraru, Andreea, et al.
Publicado: (2017)

Intraocular Pressure Elevation Following Intravitreal Anti-VEGF Injections: Short- and Long-term Considerations
por: Levin, Ariana M., et al.
Publicado: (2021)

Anti-VEGF intravitreal injections in the era of COVID-19: responding to different levels of epidemic pressure
por: Korobelnik, Jean-François, et al.
Publicado: (2021)

Clinical Features Associated with Acute Elevated Intraocular Pressure After Intravitreal Anti-VEGF Injections
por: LoBue, Stephen A, et al.
Publicado: (2023)

The remote effects of intravitreal anti-VEGF therapy
por: Balta, F, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_nijqnlmfqs1ei8pchub3qbjg2q